ArticleNeuro-oncology2022
CD55, a potential immunotherapeutic target for MYCN-amplified neuroblastoma.
Hiroyuki Yoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNeuro-oncology2022
Hiroyuki Yoda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.